NewBiologix, a technology innovation company pioneering efficient, cost-effective, and scalable production of viral vectors for gene and cell therapy, has launched a new U.S. subsidiary to better serve its growing customer base.   The new U.S. hub will offer real-time support and collaboration for gene and cell therapy companies in the world’s largest biotech market.   The company also appointed David Kelly as Business Development Manager to lead the U.S. operation and head business developm...